GlassScriptPhysician profile
Charrika Williams
NPI 1386011245
$5,969.79
in general payments reported to CMS, 2019-2025
10 companies · $383 in 2025
The $383 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $515 · 2022: $1,788 · 2023: $2,315 · 2024: $970 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,667.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,580.41 | 2022-2025 | Endurant Iis |
| Bard Peripheral Vascular, INC. | $638.89 | 2021-2022 | |
| Boston Scientific Corporation | $173.19 | 2022-2024 | Ranger |
| W. L. Gore & Associates, INC. | $146.91 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Smith+Nephew, INC. | $121.84 | 2025 | Stravix |
| Abbott Laboratories | $117.03 | 2024 | Diamondback Peripheral |
| Cardiva Medical, INC. | $92.22 | 2023 | Cardiva Vascade 5f Vcs |
| Polynovo North America LLC | $41.95 | 2024 | Novosorb Btm |
| Abbvie INC. | $35.66 | 2024 | |
| Integra Lifesciences Corporation | $21.69 | 2023 | Tcc-Ez |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charrika Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.